Impact of processed pseudogene insertions in genetic testing as cause of monogenic diseases: insertion in CLCN1 gene causing Myotonia Congenita
Back to course
Pdf Summary
Asset Subtitle
Co-Author - Kornelia Tripolszki, PhD; Co-Author - Javier Martini, MD; Co-Author - Kapil Kampe, PhD; Co-Author - Vasiliki Karageorgou, MSc; Co-Author - Mohamed Almuhaizea, MD; Co-Author - Catarina Pereira, MSc; Co-Author - Stephanie Weissgraeber, PhD; Co-Author - Omid Paknia, PhD; Presenting Author - Jorge Pinto-Basto, MD; Co-Author - Peter B. Bauer, MD;
Meta Tag
Genetic Testing
Genome sequencing
Genomic Methodologies
Musculoskeletal system
NextGen Sequencing
Sequencing
Variant Detection
Co-Author Kornelia Tripolszki, PhD
Co-Author Javier Martini, MD
Co-Author Kapil Kampe, PhD
Co-Author Vasiliki Karageorgou, MSc
Co-Author Mohamed Almuhaizea, MD
Co-Author Catarina Pereira, MSc
Co-Author Stephanie Weissgraeber, PhD
Co-Author Omid Paknia, PhD
Co-Author Peter B. Bauer, MD
Presenting Author Jorge Pinto-Basto, MD
Keywords
processed pseudogene insertions
genetic testing
monogenic diseases
autosomal recessive myotonia congenita
CLCN1 gene
muscle disorder
genomic sequencing
structural variants
retrotransposition event
rare disorders

© 2025 American College of Medical Genetics and Genomics. All rights reserved.

Powered By